These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20091557)

  • 1. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
    Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD004060. PubMed ID: 33661543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
    Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.
    Fayter D; Corbett M; Heirs M; Fox D; Eastwood A
    Health Technol Assess; 2010 Jul; 14(37):1-288. PubMed ID: 20663420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.
    Menon D; Stafinski T; Wu H; Lau D; Wong C
    BMC Gastroenterol; 2010 Sep; 10():111. PubMed ID: 20875123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
    Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
    Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett's oesophagus and stage I oesophageal adenocarcinoma.
    di Pietro M; Trudgill NJ; Vasileiou M; Longcroft-Wheaton G; Phillips AW; Gossage J; Kaye PV; Foley KG; Crosby T; Nelson S; Griffiths H; Rahman M; Ritchie G; Crisp A; Deed S; Primrose JN
    Gut; 2024 May; 73(6):897-909. PubMed ID: 38553042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's oesophagus: new diagnostic and therapeutic techniques.
    Haringsma J
    Scand J Gastroenterol Suppl; 2002; (236):9-14. PubMed ID: 12408497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of Barrett's oesophagus.
    Lim YC; Fitzgerald RC
    Br Med Bull; 2013; 107():117-32. PubMed ID: 23926313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic approaches to Barrett's oesophagus with high-grade dysplasia/early mucosal cancer.
    Ginsberg GG
    Best Pract Res Clin Gastroenterol; 2008; 22(4):751-72. PubMed ID: 18656828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management controversies in Barrett's oesophagus.
    Max Almond L; Barr H
    J Gastroenterol; 2014 Feb; 49(2):195-205. PubMed ID: 23736794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.